Pharma Turns Defensive Favourite

Pharma stocks outperformed again as investors shifted toward defensive sectors amid global uncertainty and volatile crude prices. Export-focused companies are also benefiting from rupee weakness and stable US demand. $SPARC , $CIPLA and $DRREDDY saw strong interest while broader pharma indices trying to reach fresh highs despite market volatility.